MYC and pulmonary arterial hypertension: MYC was activated following PAH treatment in our study, particularly in GSTT1-negative lymphoma cells, corresponding to increased S-phase cells, enhanced cell proliferation and in vivo tumorigenicity, indicative the possible involvement of MYC on PAH-associated cell cycle dynamics and lymphoma progression in GSTT1-null status.